{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T13:36:40Z","timestamp":1793885800445,"version":"4.8.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,17]],"date-time":"2021-09-17T00:00:00Z","timestamp":1631836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,17]],"date-time":"2021-09-17T00:00:00Z","timestamp":1631836800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000265","name":"RCUK | Medical Research Council","doi-asserted-by":"publisher","award":["MR\/M021394\/1"],"award-info":[{"award-number":["MR\/M021394\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Greg Wolf Foundation Gabrielle\u2019s Angels Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The specific niche adaptations that facilitate primary disease and Acute Lymphoblastic Leukaemia (ALL) survival after induction chemotherapy remain unclear. Here, we show that Bone Marrow (BM) adipocytes dynamically evolve during ALL pathogenesis and therapy, transitioning from cellular depletion in the primary leukaemia niche to a fully reconstituted state upon remission induction. Functionally, adipocyte niches elicit a fate switch in ALL cells towards slow-proliferation and cellular quiescence, highlighting the critical contribution of the adipocyte dynamic to disease establishment and chemotherapy resistance. Mechanistically, adipocyte niche interaction targets posttranscriptional networks and suppresses protein biosynthesis in ALL cells. Treatment with general control nonderepressible 2 inhibitor (GCN2ib) alleviates adipocyte-mediated translational repression and rescues ALL cell quiescence thereby significantly reducing the cytoprotective effect of adipocytes against chemotherapy and other extrinsic stressors. These data establish how adipocyte driven restrictions of the ALL proteome benefit ALL tumours, preventing their elimination, and suggest ways to manipulate adipocyte-mediated ALL resistance.<\/jats:p>","DOI":"10.1038\/s41467-021-25540-4","type":"journal-article","created":{"date-parts":[[2021,9,17]],"date-time":"2021-09-17T10:04:13Z","timestamp":1631873053000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Adipocytes disrupt the translational programme of acute lymphoblastic leukaemia to favour tumour survival and persistence"],"prefix":"10.1038","volume":"12","author":[{"given":"Q.","family":"Heydt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Xintaropoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Clear","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Austin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Pislariu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Miraki-Moud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3426-2274","authenticated-orcid":false,"given":"P.","family":"Cutillas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Korfi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Calaminici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7832-5057","authenticated-orcid":false,"given":"W.","family":"Cawthorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4688-4126","authenticated-orcid":false,"given":"K.","family":"Suchacki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Nagano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8505-7430","authenticated-orcid":false,"given":"J. G.","family":"Gribben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. D.","family":"Cavenagh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Oakervee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Castleton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Taussig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6687-8495","authenticated-orcid":false,"given":"B.","family":"Peck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4548-9367","authenticated-orcid":false,"given":"A.","family":"Wilczynska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"McNaughton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4735-5226","authenticated-orcid":false,"given":"D.","family":"Bonnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3896-0827","authenticated-orcid":false,"given":"F.","family":"Mardakheh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1875-8974","authenticated-orcid":false,"given":"B.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,17]]},"reference":[{"key":"25540_CR1","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1200\/JCO.2011.37.8018","volume":"30","author":"SP Hunger","year":"2012","unstructured":"Hunger, S. P. et al. Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: a report from the children\u2019s oncology group. J. Clin. Oncol. 30, 1663\u20131669 (2012).","journal-title":"J. Clin. Oncol."},{"key":"25540_CR2","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1182\/blood-2007-10-116582","volume":"111","author":"AH Goldstone","year":"2008","unstructured":"Goldstone, A. H. et al. In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation\/maintenance chemotherapy in all patients: final results of the International ALL Trial (MRC UKALL XII\/ECOG E2993). Blood 111, 1827\u20131833 (2008).","journal-title":"Blood"},{"key":"25540_CR3","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1111\/j.1365-2141.2009.07941.x","volume":"148","author":"B Patel","year":"2010","unstructured":"Patel, B. et al. Minimal residual disease is a significant predictor of treatment failure in non T-lineage adult acute lymphoblastic leukaemia: final results of the international trial UKALL XII\/ECOG2993. Br. J. Haematol. 148, 80\u201389 (2010).","journal-title":"Br. J. Haematol."},{"key":"25540_CR4","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1182\/blood-2011-09-377713","volume":"120","author":"N Gokbuget","year":"2012","unstructured":"Gokbuget, N. et al. Adult patients with acute lymphoblastic leukemia and molecular failure display a poor prognosis and are candidates for stem cell transplantation and targeted therapies. Blood 120, 1868\u20131876 (2012).","journal-title":"Blood"},{"key":"25540_CR5","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1182\/blood-2005-07-2708","volume":"107","author":"M Bruggemann","year":"2006","unstructured":"Bruggemann, M. et al. Clinical significance of minimal residual disease quantification in adult patients with standard-risk acute lymphoblastic leukemia. Blood 107, 1116\u20131123 (2006).","journal-title":"Blood"},{"key":"25540_CR6","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.ccell.2016.11.002","volume":"30","author":"S Ebinger","year":"2016","unstructured":"Ebinger, S. et al. Characterization of rare, dormant, and therapy-resistant cells in acute lymphoblastic leukemia. Cancer Cell 30, 849\u2013862 (2016).","journal-title":"Cancer Cell"},{"key":"25540_CR7","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1038\/leu.2012.306","volume":"27","author":"C Lutz","year":"2013","unstructured":"Lutz, C. et al. Quiescent leukaemic cells account for minimal residual disease in childhood lymphoblastic leukaemia. Leukemia 27, 1204\u20131207 (2013).","journal-title":"Leukemia"},{"key":"25540_CR8","doi-asserted-by":"publisher","first-page":"4188","DOI":"10.1038\/s41598-019-40786-1","volume":"9","author":"MP Schroeder","year":"2019","unstructured":"Schroeder, M. P. et al. Integrated analysis of relapsed B-cell precursor Acute Lymphoblastic Leukemia identifies subtype-specific cytokine and metabolic signatures. Sci. Rep. 9, 4188\u20134188 (2019).","journal-title":"Sci. Rep."},{"key":"25540_CR9","doi-asserted-by":"crossref","unstructured":"Dobson, S. M. et al. Relapse-fated latent diagnosis subclones in acute B lineage leukemia are drug tolerant and possess distinct metabolic programs. Cancer Discov. 10, 568\u2013587 (2020).","DOI":"10.1158\/2159-8290.CD-19-1059"},{"key":"25540_CR10","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/nrc2714","volume":"9","author":"MB Meads","year":"2009","unstructured":"Meads, M. B., Gatenby, R. A. & Dalton, W. S. Environment-mediated drug resistance: a major contributor to minimal residual disease. Nat. Rev. Cancer 9, 665\u2013674 (2009).","journal-title":"Nat. Rev. Cancer"},{"key":"25540_CR11","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/nri.2017.53","volume":"17","author":"GM Crane","year":"2017","unstructured":"Crane, G. M., Jeffery, E. & Morrison, S. J. Adult haematopoietic stem cell niches. Nat. Rev. Immunol. 17, 573\u2013590 (2017).","journal-title":"Nat. Rev. Immunol."},{"key":"25540_CR12","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41556-019-0444-9","volume":"22","author":"A Batsivari","year":"2020","unstructured":"Batsivari, A. et al. Dynamic responses of the haematopoietic stem cell niche to diverse stresses. Nat. Cell Biol. 22, 7\u201317 (2020).","journal-title":"Nat. Cell Biol."},{"key":"25540_CR13","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.ccr.2012.02.018","volume":"21","author":"B Zhang","year":"2012","unstructured":"Zhang, B. et al. Altered microenvironmental regulation of leukemic and normal stem cells in chronic myelogenous leukemia. Cancer Cell 21, 577\u2013592 (2012).","journal-title":"Cancer Cell"},{"key":"25540_CR14","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/j.ccr.2014.04.015","volume":"25","author":"CW Duan","year":"2014","unstructured":"Duan, C. W. et al. Leukemia propagating cells rebuild an evolving niche in response to therapy. Cancer Cell 25, 778\u2013793 (2014).","journal-title":"Cancer Cell"},{"key":"25540_CR15","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1126\/science.1164390","volume":"322","author":"A Colmone","year":"2008","unstructured":"Colmone, A. et al. Leukemic cells create bone marrow niches that disrupt the behavior of normal hematopoietic progenitor cells. Science 322, 1861\u20131865 (2008).","journal-title":"Science"},{"key":"25540_CR16","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.stem.2014.06.020","volume":"15","author":"M Hanoun","year":"2014","unstructured":"Hanoun, M. et al. Acute myelogenous leukemia-induced sympathetic neuropathy promotes malignancy in an altered hematopoietic stem cell niche. Cell Stem Cell 15, 365\u2013375 (2014).","journal-title":"Cell Stem Cell"},{"key":"25540_CR17","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1038\/nature19801","volume":"538","author":"ED Hawkins","year":"2016","unstructured":"Hawkins, E. D. et al. T-cell acute leukaemia exhibits dynamic interactions with bone marrow microenvironments. Nature 538, 518\u2013522 (2016).","journal-title":"Nature"},{"key":"25540_CR18","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/s41586-019-1104-8","volume":"569","author":"AN Tikhonova","year":"2019","unstructured":"Tikhonova, A. N. et al. The bone marrow microenvironment at single-cell resolution. Nature 569, 222\u2013228 (2019).","journal-title":"Nature"},{"key":"25540_CR19","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1016\/j.cell.2019.04.040","volume":"177","author":"N Baryawno","year":"2019","unstructured":"Baryawno, N. et al. A cellular taxonomy of the bone marrow stroma in homeostasis and leukemia. Cell 177, 1915\u20131932.e1916 (2019).","journal-title":"Cell"},{"key":"25540_CR20","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.stem.2019.06.003","volume":"25","author":"N Severe","year":"2019","unstructured":"Severe, N. et al. Stress-induced changes in bone marrow stromal cell populations revealed through single-cell protein expression mapping. Cell Stem Cell 25, 570\u2013583.e577 (2019).","journal-title":"Cell Stem Cell"},{"key":"25540_CR21","doi-asserted-by":"publisher","first-page":"5136","DOI":"10.1182\/blood-2009-08-231217","volume":"114","author":"DI Marks","year":"2009","unstructured":"Marks, D. I. et al. T-cell acute lymphoblastic leukemia in adults: clinical features, immunophenotype, cytogenetics, and outcome from the large randomized prospective trial (UKALL XII\/ECOG 2993). Blood 114, 5136\u20135145 (2009).","journal-title":"Blood"},{"key":"25540_CR22","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.ccell.2015.05.002","volume":"27","author":"LA Pitt","year":"2015","unstructured":"Pitt, L. A. et al. CXCL12-producing vascular endothelial niches control acute T cell leukemia maintenance. Cancer Cell 27, 755\u2013768 (2015).","journal-title":"Cancer Cell"},{"key":"25540_CR23","doi-asserted-by":"publisher","first-page":"2998","DOI":"10.1158\/0008-5472.CAN-12-4402","volume":"73","author":"EA Ehsanipour","year":"2013","unstructured":"Ehsanipour, E. A. et al. Adipocytes cause leukemia cell resistance to L-asparaginase via release of glutamine. Cancer Res. 73, 2998\u20133006 (2013).","journal-title":"Cancer Res."},{"key":"25540_CR24","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1182\/bloodadvances.2017004960","volume":"1","author":"X Cahu","year":"2017","unstructured":"Cahu, X. et al. Bone marrow sites differently imprint dormancy and chemoresistance to T-cell acute lymphoblastic leukemia. Blood Adv. 1, 1760 (2017).","journal-title":"Blood Adv."},{"key":"25540_CR25","doi-asserted-by":"publisher","first-page":"7867","DOI":"10.1158\/0008-5472.CAN-09-0800","volume":"69","author":"JW Behan","year":"2009","unstructured":"Behan, J. W. et al. Adipocytes impair leukemia treatment in mice. Cancer Res. 69, 7867\u20137874 (2009).","journal-title":"Cancer Res."},{"key":"25540_CR26","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1158\/1541-7786.MCR-17-0338","volume":"15","author":"X Sheng","year":"2017","unstructured":"Sheng, X. et al. Adipocytes sequester and metabolize the chemotherapeutic daunorubicin. Mol. Cancer Res. 15, 1704\u20131713 (2017).","journal-title":"Mol. Cancer Res."},{"key":"25540_CR27","doi-asserted-by":"publisher","first-page":"73147","DOI":"10.18632\/oncotarget.12246","volume":"7","author":"X Sheng","year":"2016","unstructured":"Sheng, X. et al. Adipocytes cause leukemia cell resistance to daunorubicin via oxidative stress response. Oncotarget 7, 73147\u201373159 (2016).","journal-title":"Oncotarget"},{"key":"25540_CR28","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.1159\/000488225","volume":"45","author":"H Liu","year":"2018","unstructured":"Liu, H. et al. Consolidation chemotherapy prevents relapse by indirectly regulating bone marrow adipogenesis in patients with acute myeloid leukemia. Cell Physiol. Biochem. 45, 2389\u20132400 (2018).","journal-title":"Cell Physiol. Biochem."},{"key":"25540_CR29","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1002\/stem.2640","volume":"35","author":"Y Masamoto","year":"2017","unstructured":"Masamoto, Y. et al. Adiponectin enhances quiescence exit of murine hematopoietic stem cells and hematopoietic recovery through mTORC1 potentiation. Stem Cells 35, 1835\u20131848 (2017).","journal-title":"Stem Cells"},{"key":"25540_CR30","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/14653240600855905","volume":"8","author":"M Dominici","year":"2006","unstructured":"Dominici, M. et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8, 315\u2013317 (2006).","journal-title":"Cytotherapy"},{"key":"25540_CR31","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1038\/ncb3625","volume":"19","author":"AL Boyd","year":"2017","unstructured":"Boyd, A. L. et al. Acute myeloid leukaemia disrupts endogenous myelo-erythropoiesis by compromising the adipocyte bone marrow niche. Nat. Cell Biol. 19, 1336\u20131347 (2017).","journal-title":"Nat. Cell Biol."},{"key":"25540_CR32","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1186\/s13287-018-1013-z","volume":"9","author":"G Corradi","year":"2018","unstructured":"Corradi, G. et al. Mesenchymal stromal cells from myelodysplastic and acute myeloid leukemia patients display in vitro reduced proliferative potential and similar capacity to support leukemia cell survival. Stem Cell Res. Ther. 9, 271 (2018).","journal-title":"Stem Cell Res. Ther."},{"key":"25540_CR33","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/s41375-019-0568-8","volume":"34","author":"M Azadniv","year":"2020","unstructured":"Azadniv, M. et al. Bone marrow mesenchymal stromal cells from acute myelogenous leukemia patients demonstrate adipogenic differentiation propensity with implications for leukemia cell support. Leukemia 34, 391\u2013403 (2020).","journal-title":"Leukemia"},{"key":"25540_CR34","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/0092-8674(75)90087-2","volume":"5","author":"H Green","year":"1975","unstructured":"Green, H. & Kehinde, O. An established preadipose cell line and its differentiation in culture. II. Factors affecting the adipose conversion. Cell 5, 19\u201327 (1975).","journal-title":"Cell"},{"key":"25540_CR35","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/nature08099","volume":"460","author":"O Naveiras","year":"2009","unstructured":"Naveiras, O. et al. Bone-marrow adipocytes as negative regulators of the haematopoietic microenvironment. Nature 460, 259\u2013263 (2009).","journal-title":"Nature"},{"key":"25540_CR36","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1038\/ncb3570","volume":"19","author":"BO Zhou","year":"2017","unstructured":"Zhou, B. O. et al. Bone marrow adipocytes promote the regeneration of stem cells and haematopoiesis by secreting SCF. Nat. Cell Biol. 19, 891\u2013903 (2017).","journal-title":"Nat. Cell Biol."},{"key":"25540_CR37","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1182\/blood-2016-08-734798","volume":"129","author":"MS Shafat","year":"2017","unstructured":"Shafat, M. S. et al. Leukemic blasts program bone marrow adipocytes to generate a protumoral microenvironment. Blood 129, 1320\u20131332 (2017).","journal-title":"Blood"},{"key":"25540_CR38","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1038\/nm.2492","volume":"17","author":"KM Nieman","year":"2011","unstructured":"Nieman, K. M. et al. Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth. Nat. Med 17, 1498\u20131503 (2011).","journal-title":"Nat. Med"},{"key":"25540_CR39","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.stem.2016.06.001","volume":"19","author":"H Ye","year":"2016","unstructured":"Ye, H. et al. Leukemic stem cells evade chemotherapy by metabolic adaptation to an adipose tissue niche. Cell Stem Cell 19, 23\u201337 (2016).","journal-title":"Cell Stem Cell"},{"key":"25540_CR40","doi-asserted-by":"publisher","first-page":"rs6","DOI":"10.1126\/scisignal.2003573","volume":"6","author":"P Casado","year":"2013","unstructured":"Casado, P. et al. Kinase-substrate enrichment analysis provides insights into the heterogeneity of signaling pathway activation in leukemia cells. Sci. Signal 6, rs6 (2013).","journal-title":"Sci. Signal"},{"key":"25540_CR41","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1038\/s41375-020-0886-x","volume":"34","author":"J Zinngrebe","year":"2020","unstructured":"Zinngrebe, J., Debatin, K. M. & Fischer-Posovszky, P. Adipocytes in hematopoiesis and acute leukemia: friends, enemies, or innocent bystanders? Leukemia 34, 2305\u20132316 (2020).","journal-title":"Leukemia"},{"key":"25540_CR42","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.stem.2017.02.009","volume":"20","author":"TH Ambrosi","year":"2017","unstructured":"Ambrosi, T. H. et al. Adipocyte accumulation in the bone marrow during obesity and aging impairs stem cell-based hematopoietic and bone regeneration. Cell Stem Cell 20, 771\u2013784. e776 (2017).","journal-title":"Cell Stem Cell"},{"key":"25540_CR43","doi-asserted-by":"publisher","first-page":"94","DOI":"10.15698\/mic2015.04.198","volume":"2","author":"M Polymenis","year":"2015","unstructured":"Polymenis, M. & Aramayo, R. Translate to divide: small es, Cyrillicontrol of the cell cycle by protein synthesis. Micro. Cell 2, 94\u2013104 (2015).","journal-title":"Micro. Cell"},{"key":"25540_CR44","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.cell.2006.01.016","volume":"124","author":"S Wullschleger","year":"2006","unstructured":"Wullschleger, S., Loewith, R. & Hall, M. N. TOR signaling in growth and metabolism. Cell 124, 471\u2013484 (2006).","journal-title":"Cell"},{"key":"25540_CR45","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1038\/nrm1618","volume":"6","author":"M Holcik","year":"2005","unstructured":"Holcik, M. & Sonenberg, N. Translational control in stress and apoptosis. Nat. Rev. Mol. Cell Biol. 6, 318\u2013327 (2005).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"25540_CR46","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/j.cell.2016.06.042","volume":"166","author":"KA Goncalves","year":"2016","unstructured":"Goncalves, K. A. et al. Angiogenin promotes hematopoietic regeneration by dichotomously regulating quiescence of stem and progenitor cells. Cell 166, 894\u2013906 (2016).","journal-title":"Cell"},{"key":"25540_CR47","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/nature13035","volume":"509","author":"RA Signer","year":"2014","unstructured":"Signer, R. A., Magee, J. A., Salic, A. & Morrison, S. J. Haematopoietic stem cells require a highly regulated protein synthesis rate. Nature 509, 49\u201354 (2014).","journal-title":"Nature"},{"key":"25540_CR48","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1182\/bloodadvances.2017004960","volume":"1","author":"X Cahu","year":"2017","unstructured":"Cahu, X. et al. Bone marrow sites differently imprint dormancy and chemoresistance to T-cell acute lymphoblastic leukemia. Blood Adv. 1, 1760\u20131772 (2017).","journal-title":"Blood Adv."},{"key":"25540_CR49","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.ccell.2020.12.002","volume":"39","author":"E Dhimolea","year":"2021","unstructured":"Dhimolea, E. et al. An embryonic diapause-like adaptation with suppressed Myc activity enables tumor treatment persistence. Cancer cell 39, 240\u2013256.e211 (2021).","journal-title":"Cancer cell"},{"key":"25540_CR50","doi-asserted-by":"publisher","first-page":"a004440","DOI":"10.1101\/cshperspect.a004440","volume":"3","author":"RC Taylor","year":"2011","unstructured":"Taylor, R. C. & Dillin, A. Aging as an event of proteostasis collapse. Cold Spring Harb. Perspect. Biol. 3, a004440 (2011).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"25540_CR51","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1210\/en.2003-0746","volume":"145","author":"SO Rzonca","year":"2004","unstructured":"Rzonca, S. O., Suva, L. J., Gaddy, D., Montague, D. C. & Lecka-Czernik, B. Bone is a target for the antidiabetic compound rosiglitazone. Endocrinology 145, 401\u2013406 (2004).","journal-title":"Endocrinology"},{"key":"25540_CR52","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1002\/cbf.3025","volume":"32","author":"JJ Patel","year":"2014","unstructured":"Patel, J. J., Butters, O. R. & Arnett, T. R. PPAR agonists stimulate adipogenesis at the expense of osteoblast differentiation while inhibiting osteoclast formation and activity. Cell Biochem. Funct. 32, 368\u2013377 (2014).","journal-title":"Cell Biochem. Funct."},{"key":"25540_CR53","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/nrendo.2014.94","volume":"10","author":"J Park","year":"2014","unstructured":"Park, J., Morley, T. S., Kim, M., Clegg, D. J. & Scherer, P. E. Obesity and cancer\u2013mechanisms underlying tumour progression and recurrence. Nat. Rev. Endocrinol. 10, 455\u2013465 (2014).","journal-title":"Nat. Rev. Endocrinol."},{"key":"25540_CR54","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1021\/acsmedchemlett.9b00400","volume":"10","author":"J Fujimoto","year":"2019","unstructured":"Fujimoto, J. et al. Identification of novel, potent, and orally available GCN2 inhibitors with type I half binding mode. ACS Med Chem. Lett. 10, 1498\u20131503 (2019).","journal-title":"ACS Med Chem. Lett."},{"key":"25540_CR55","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.plipres.2017.11.002","volume":"69","author":"J Choi","year":"2018","unstructured":"Choi, J., Cha, Y. J. & Koo, J. S. Adipocyte biology in breast cancer: from silent bystander to active facilitator. Prog. Lipid Res. 69, 11\u201320 (2018).","journal-title":"Prog. Lipid Res."},{"key":"25540_CR56","doi-asserted-by":"publisher","first-page":"S348","DOI":"10.21037\/tau.2019.04.07","volume":"8","author":"MG Kolonin","year":"2019","unstructured":"Kolonin, M. G. & DiGiovanni, J. The role of adipose stroma in prostate cancer aggressiveness. Transl. Androl. Urol. 8, S348\u2013s350 (2019).","journal-title":"Transl. Androl. Urol."},{"key":"25540_CR57","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.3324\/haematol.2017.173492","volume":"103","author":"L Wei","year":"2018","unstructured":"Wei, L. et al. Small bone marrow adipocytes predict poor prognosis in acute myeloid leukemia. Haematologica 103, e21\u2013e24 (2018).","journal-title":"Haematologica"},{"key":"25540_CR58","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1182\/blood.V56.2.289.289","volume":"56","author":"H Castro-Malaspina","year":"1980","unstructured":"Castro-Malaspina, H. et al. Characterization of human bone marrow fibroblast colony-forming cells (CFU-F) and their progeny. Blood 56, 289\u2013301 (1980).","journal-title":"Blood"},{"key":"25540_CR59","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1210\/me.2005-0536","volume":"20","author":"R Nawaratne","year":"2006","unstructured":"Nawaratne, R. et al. Regulation of insulin receptor substrate 1 pleckstrin homology domain by protein kinase C: role of serine 24 phosphorylation. Mol. Endocrinol. 20, 1838\u20131852 (2006).","journal-title":"Mol. Endocrinol."},{"key":"25540_CR60","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1038\/sj.cdd.4402127","volume":"14","author":"WP Cawthorn","year":"2007","unstructured":"Cawthorn, W. P., Heyd, F., Hegyi, K. & Sethi, J. K. Tumour necrosis factor-alpha inhibits adipogenesis via a beta-catenin\/TCF4(TCF7L2)-dependent pathway. Cell Death Differ. 14, 1361\u20131373 (2007).","journal-title":"Cell Death Differ."},{"key":"25540_CR61","unstructured":"Isaac, G., McDonald, S. & Astarita, G. Lipid Separation: UPLC System for the Separation of Complex Biological Total Lipid Extracts (Water Application note 2011)."},{"key":"25540_CR62","doi-asserted-by":"publisher","first-page":"7719","DOI":"10.1073\/pnas.1423344112","volume":"112","author":"EH Wilkes","year":"2015","unstructured":"Wilkes, E. H., Terfve, C., Gribben, J. G., Saez-Rodriguez, J. & Cutillas, P. R. Empirical inference of circuitry and plasticity in a kinase signaling network. Proc. Natl Acad. Sci. USA 112, 7719\u20137724 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"25540_CR63","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/bs.mie.2016.09.021","volume":"585","author":"PR Cutillas","year":"2017","unstructured":"Cutillas, P. R. Targeted In-depth quantification of signaling using label-free mass spectrometry. Methods Enzymol. 585, 245\u2013268 (2017).","journal-title":"Methods Enzymol."},{"key":"25540_CR64","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-6-144","volume":"6","author":"SY Kim","year":"2005","unstructured":"Kim, S. Y. & Volsky, D. J. PAGE: parametric analysis of gene set enrichment. BMC Bioinform. 6, 144 (2005).","journal-title":"BMC Bioinform."},{"key":"25540_CR65","doi-asserted-by":"publisher","first-page":"D512","DOI":"10.1093\/nar\/gku1267","volume":"43","author":"PV Hornbeck","year":"2015","unstructured":"Hornbeck, P. V. et al. PhosphoSitePlus, 2014: mutations, PTMs and recalibrations. Nucleic Acids Res. 43, D512\u2013D520 (2015).","journal-title":"Nucleic Acids Res."},{"key":"25540_CR66","doi-asserted-by":"publisher","first-page":"D261","DOI":"10.1093\/nar\/gkq1104","volume":"39","author":"H Dinkel","year":"2011","unstructured":"Dinkel, H. et al. Phospho.ELM: a database of phosphorylation sites\u2013update 2011. Nucleic Acids Res 39, D261\u2013D267 (2011).","journal-title":"Nucleic Acids Res"},{"key":"25540_CR67","doi-asserted-by":"publisher","first-page":"i14","DOI":"10.1093\/bioinformatics\/btn297","volume":"24","author":"CY Yang","year":"2008","unstructured":"Yang, C. Y. et al. PhosphoPOINT: a comprehensive human kinase interactome and phospho-protein database. Bioinformatics 24, i14\u2013i20 (2008).","journal-title":"Bioinformatics"},{"key":"25540_CR68","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1182\/blood-2014-01-549352","volume":"124","author":"B Patel","year":"2014","unstructured":"Patel, B. et al. Mouse xenograft modeling of human adult acute lymphoblastic leukemia provides mechanistic insights into adult LIC biology. Blood 124, 96\u2013105 (2014).","journal-title":"Blood"},{"key":"25540_CR69","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.devcel.2015.10.005","volume":"35","author":"FK Mardakheh","year":"2015","unstructured":"Mardakheh, F. K. et al. Global analysis of mRNA, translation, and protein localization: local translation is a key regulator of cell protrusions. Dev. Cell 35, 344\u2013357 (2015).","journal-title":"Dev. Cell"},{"key":"25540_CR70","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1038\/nprot.2016.136","volume":"11","author":"S Tyanova","year":"2016","unstructured":"Tyanova, S., Temu, T. & Cox, J. The MaxQuant computational platform for mass spectrometry-based shotgun proteomics. Nat. Protoc. 11, 2301\u20132319 (2016).","journal-title":"Nat. Protoc."},{"key":"25540_CR71","doi-asserted-by":"crossref","unstructured":"Tyanova, S., Temu, T. & Sinitcyn, P. The Perseus computational platform for comprehensive analysis of (prote)omics data. Nat. Methods 13, 731\u2013740 (2016).","DOI":"10.1038\/nmeth.3901"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-25540-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-25540-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-25540-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T14:47:48Z","timestamp":1669992468000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-25540-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,17]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["25540"],"URL":"https:\/\/doi.org\/10.1038\/s41467-021-25540-4","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,17]]},"assertion":[{"value":"3 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5507"}}